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ABSTRACT
Objectives: To determine the outcome of therapeutic hydrotubation (tubal flushing) 
in patients with tubal infertility and unexplained infertility.
Design: Prospective non-randomised observational study.
Setting: Alba hospital, a five bed multidisciplinary private hospital in Kaduna city, 
Nigeria. 
Subjects: Infertile women with tubal and unexplained infertility.
Results: Two hundred and fifty seven patients that had therapeutic hydrotubation 
over 7.5 years were analysed. The age range was 21 to 44 years with mean of 34.5 years. 
Secondary infertility was found in 209 (81.3%) patients and primary infertility in 166 
(64.6%) patients. Of the 257 patients, 134 (52.1%) had had induced abortion. Indications 
for hydrotubation were bilateral perifimbrial adhesion (incomplete tubal occlusion) 
47.9%, bilateral fimbrial end occlusion 24.9%, bilateral cornual blockage 16% and 
unexplained infertility in 11.3% of cases. One hundred and nine conceptions were 
recorded in this study and the overall conception rate was 42.4%. Likewise, percentage 
ratio of conception in these 154 patients with evidence of post – hydrotubation tubal 
patency was 70.8%. Pregnancy outcome of the 109 conceptions are term pregnancy 
84.4%, preterm pregnancy 9.2%, miscarriage 4.6% and ectopic pregnancy in 1.8% of 
the conceptions. Recorded complications were pelvic pain in 177 (68.9%) patients and 
vaginal bleeding in 63 (24.5%) patients.
Conclusion: With good case selection, therapeutic hydrotubation may be beneficial in 
resource poor countries, especially in patients with incomplete tubal occlusion (bilateral 
perifimbrial adhesions) and as part of treatment for unexplained infertility.
INTRODUCTION
Infertility remains a major reason for gynaecological 
consultation in developing countries. It is associated 
with social consequences like marital instability, 
divorce, polygamy, prostitution and suicide in 
extreme cases. In the tropics, tubal factors remain a 
common cause of female infertility (1). This is due to 
high prevalence of sexually transmitted diseases in 
our setting. Optimal diagnosis and treatment of tubal 
factor, though standardised, vary from place to place, 
depending on how developed the health care services 
are. Methods of managing tubal factors in infertility 
range from gaseous insufflation, hydrotubation, 
microsurgery, hysteroscopic catheterisation and 
in vitro fertilisation (2).
 Microsurgical operations and hysteroscopic 
catheterisation technology are not available in 
our setting. Although there are very few in vitro 
fertilisation (IVF) units, the services are usually 
unaffordable and out of reach to majority of patients 
that may benefit from it. The recently introduced 
National Health Insurance Scheme in the country 
does not cater for this service. It costs between 
four to six thousand United States Dollars for one 
IVF cycle. Against this background, we performed 
hydrotubation on most of these patients as a last 
resort. 
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MATERIALS AND METHODS
This was a prospective study carried out in a privately 
owned 50 bed multidisciplinary hospital in Kaduna 
City, Nigeria. The study period was from January 
1999 through to June 2006. During this period, 291 
hydrotubation (HTB) procedures were done, but 257 
cases that were followed up for at least six months 
post-procedure were analysed in this study.
 The inclusion criteria and indications for 
hydrotubation were bilateral tubal pathology and 
unexplained infertility. Patients with hydrosalpinx, 
occlusion in the mid portion of the fallopian tubes 
and unilateral patent tubes were excluded from this 
study. The patients were screened and appropriately 
treated for pelvic infection before they were subjected 
to hysterosalpingogram (HSG) and subsequently 
hydrotubation. Patients also had pelvic sonogram 
pre and post procedure. The essence of the pre-HTB 
pelvic sonogram was to rule out free fluid collection 
in the pelvis, so as not to mistake it for successful 
HTB evidenced by free fluid collection in the pelvis 
post-HTB. Laparoscopy and dye hydrotubation was 
not done for most patients, due to affordability and 
availability to laparoscopic evaluation in low resource 
setting like ours.
 Hydrotubation was carried out as an outpatient 
procedure during the 6th to the 10th day of a menstrual 
cycle. The patients received short acting intravenous 
(sodium thiopentone) anaesthetic agent. The cervix 
was canullated with a Leech-Wilkinsons canullae 
and 50mls loaded syringe attached to the canullae 
was used to flush the fallopian tubes. The solution 
for HTB was made up of normal saline, crystalline 
penicillin and hydrocostisone; 50 to 100mls of the 
solution was used per procedure.
 Post procedure, patients were transferred to 
the recovery room, where they were given a dose of 
injectable non-steroidal anti-inflammatory analgesia. 
Following full recovery, they were discharged on 
analgesics and prophylactic antibiotics. Repeat HTB 
was done for some patients in subsequent menstrual 
cycle(s) due to marked resistance and reflux of the 
solution.
 They were followed up in the gynaecological 
clinic. Their first visit was the next menstrual cycle, 
during which ultrasound scan was performed to 
confirm ovulatory cycle and were counselled on 
timed intercourse. Those patients with anovulatory 
cycle were placed on clomiphene citrate in subsequent 
menstral cycles.
 The 257 patients that had hydrotubation were 
divided into four main groups as follows:
Group A:  Patients that had bilateral cornual occlusion 
of the fallopian tubes on HSG.
Group B: Patients that had bilateral fimbrial end tubal 
occlusion on HSG.
Group C: Patients that had bilateral peri-fimbrial 
adhesion evidenced by loculated and restricted 
spillage of contrast on HSG.
Group D: Patients with unexplained infertility and 
evidence of patent  tubes on HSG.
RESULTS
A total of 257 patients that had hydrotubation over a 
period of 7.5 years were analysed. Of the 257 patients, 
154 (59.5%) had evidence of post – HTB patency of 
the fallopian tube(s) confirmed with sonogram and 
109 (42.4%) patients out of the latter went ahead to 
conceive.
Patients profile: The mean age of the patients was 
34.5 years with age range of 21 to 44 years. Of the 
357 patients, 99 (38.5%) had never delivered before 
and the highest number of childbirths amongst 
the category of patients that had delivered before 
was three. Seventy five (29.2%) patients had no 
history of previous abortions. Spontaneous abortion 
accounted for  48 (18.7%) patients of cases and 
induced abortion 118 (45.9%)patients while the 
remaining six (6.2%) patients  had both spontaneous 
and induced abortion. When extrapolated, 134 
(52.1%) (Table 1) patients had previous history of 
induced abortion.
 Secondary infertility was the commonest type 
of infertility in 209 (81.3%) patients and 166 (64.6%) 
patients had been infertile for durations of 1 to 5 
years. Frequency of hydrotubation in this study 
showed that 233 (90.7%) patients had it once, 21 
(8.2%) patients twice and three (1.2%) patients had 
it thrice.
Indications for hydrotubation and pregnancy attainment: 
The indications for hydrotubation showed that 
patients with bilateral perifimbrial adhesions, that is 
incomplete tubal occlusion (group C) accounted for 
123 (47.9%) of cases. This was followed by bilateral 
fimbrial end blockage (group B) 64  (24.9%) patients , 
bilateral cornual blockage (group A) 41 (16%) patients 
and patients with unexplained infertility (group D) 
accounted for  29 (11.3%) patients of cases.
 Percentage ratio of conception per indications 
for hydrotubation, showed that the highest 
conception per indication (56.1%) was achieved 
in group C and the least (24.3%) in group A. This 
reveals that hydrotubation is more effective in 
treating patients with incomplete tubal occlusion 
(perifimbrial adhesions), followed by unexplained 
infertility, perifimbrial occlusion and cornual 
blockage (Table 2). In this study, the overall 
conception rate following hydrotubation was 
42.4%.
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Table 1
Profile of patients (n = 257)
Variable No. (%)
Age (years)
  20 – 30 89 34.6
  31 – 40 134 52.2
  41 - 50 34 13.2
Previous delivery
  0  99 38.5
  1 113 44.0
  2 28 10.9
  3 17 6.6
Previous abortion
  Nil abortion 75 29.2
  Spontaneous 48 18.7
  Induced 118 45.9
  Spontaneous and induced 16 6.2
Type of infertility
  Primary 48 18.7
  Secondary 209 81.3
Duration of infertility (years)
  1 – 5 166 28.0
  6 – 10 72 64.6
  >11 19 7.4
Frequency of hydrotubation
  Once 233 90.7
  Twice 21 8.2
  Thrice 3 1.2
Table 2 
Group distribution of patients and post hydrotubation attainment of conception (n = 257)
                   Group Attainment of Percentage ratio of
  conception conception per group
 No. (%) No. (%) (%)
A 41  16.0 10 9.2 24.3
B 64 24.9 19 17.4 29.7
C 123 47.9 69 63.3 56.1
D 29 11.3 11 10.1 38.0
Overall rate of conception = 42.4%
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Post hydrotubation tubal patency and attainment of 
conception: Tubal patency was confirmed in 154 
patient post – HTB with pelvic sonography and 
109 conceptions were subsequently recorded. All 
patients that conceived in this study had evidence 
of tubal patency post – HTB. This gives us an overall 
percentage ratio of 70.8% conceptions following post 
– HTB evidence of tubal patency.
 Except for patients with unexplained infertility 
(group D), the percentage ratio of conception 
positively correlated with evidence of tubal patency 
following hydrotubation (Table 3). This means that 
patients with post HTB confirmation of tubal patency 
with sonogram have more chances to conceive 
compared to patients with no evidence of post – HTB 
tubal patency.
Post hydrotubation attainment of conception with or 
without clomiphene citrate: From Table 4, a significant 
percentage (63.6%) of patients with unexplained 
infertility (group D) had to use clomiphene citrate 
before they could conceive post hydrotubation. On 
the contrary, greater percentage of patients in group 
A (80%), group B (68.4%) and group C (79.7%) did 
not use clomiphene citrate before they achieved 
conception post hydrotubation.
Complications of hydrotubation and pregnancy outcome: 
There was no major complication recorded in 
this study that warrants hospitalisation. Minor 
complication/complaints encountered were pelvic 
pain in 177 (68.9%) patients and vaginal bleeding in 
63 (24.5%) patients. These patients were treated on 
outpatient basis.
 The outcome of the 109 conceptions revealed 
that 92 (84.4%) ended up in term pregnancy, 10 
(9.2%) in preterm delivery and five (4.6%) in 
miscarriage. Two (1.8%) conceptions were ectopic 
pregnancies (Table 5).
Table 3
 Evidence of post hydrotubation tubal patency and conception rate in the groups
Group             Post – HTB  Attainment of Percentage ratio
                tubal patency (n = 154) conception (n = 109) of conception 
    post–HTB patency
 No.  (%) No.  (%) (%)
A 17 11.0 10 9.2 58.8
B 26 16.9 19 17.2 73.1
C 82 53.3 69 63.3 84.1
D 29 18.8 11 10.1 37.9
Overall percentage ratio of conception following evidence of post – HTB tubal patency = 70.8%
*HTB=Hydrotubation
Table 4 
Group distribution of patients and post-HTB conception with or without clomiphene citrate
Group Number of  Conception with Conception without
 conception  Clomiphene Citrate Clomiphene Citrate
A 10 8 80.0% 2 20.0%
B 19 13 68.4% 6 31.6%
C 69 55 79.7% 14 20.3%
D 11 4 36.4% 7 63.6%
* HTB=Hydrotubation
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Table 5 
Outcome of pregnancy (n = 109)
Variable No. (%)
Term pregnancy 92 84.4




The assessment of fallopian tubes patency is an 
integral and pertinent step in the evaluation of female 
infertility (3). Also, the treatment of tubal factor in 
infertility management is most difficult and subject 
to debates (2). In this study, hysterosalpingogram 
was used to assess patency of the fallopian tubes 
though not as accurate as laparoscopy and dye test, 
it has been reported to have positive predictive value 
between 61.7 to 73% (4,5).
 Hydrotubation for therapeutic intervention 
was employed as a last resort of treatment for these 
patients because it is a simple, cheap and minimally 
invasive procedure with low risk of complications. 
The inclusion of antibiotic (crystalline penicillin) 
and steroid (hydrocortisone) in the formulation of 
hydrotubation solution used in this study, was based 
on study by Johnson and Watson (6) that reported 
reduced infection and increased pregnancy with live 
birth rate when used after reproductive pelvic surgery 
to enhance fertility.
 Other studies (7,8) have reported fertility 
enhancing effect of tubal flushing especially with 
oil soluble medium, we used saline solution in 
our study due to the side effects of oil media 
and because our intervention was principally for 
therapeutic reason. Oil media have been associated 
with persistent contrast medium within the pelvis, 
allergy or anaphylaxis reaction from intravasation 
and formation of lipogranuloma on a long term. It 
is therefore not surprising that we only recorded 
minor complaints with the use of water medium in 
our study. The patients in our series had pre – HTB 
screening for pelvic infection and post – HTB antibiotic 
prophylaxis. We were guided in this direction by the 
recommendation of the Royal College of Obstetricians 
and Gynaecologists (9) for women going for uterine 
instrumentation and the finding of clinical infection 
following hysterosalpingogram by Forsey et al (10).
 Secondary infertility was predominant in our 
study. Similarly, Bello (11) found tubal pathology to 
be significantly associated with secondary infertility 
than primary infertility. Also noteworthy from our 
series, is that more than half of our patients had 
had induced abortion, most likely in an unsafe 
environment due to illegality attached to it in our 
country. Therefore, the contribution of unsafe abortion 
in the aetiopathogenesis of tubal disease in our 
infertile women cannot be overestimated.
 We employed post – HTB sonogram to assess 
patency of the fallopian tube(s) following the 
procedure. This was based on results of other studies 
that reported accuracy rate of diagnostic saline HTB 
ranging from 82.9 to 87.1% (5,12). Excluding patients 
with unexplained infertility, our results show that the 
chances of conception increased with evidence of post 
– HTB tubal patency. Furthermore, evidence of post 
– HTB tubal patency is of most predictive value in 
terms of conception rate in patients with perifimbrial 
adhesions and least in patients with unexplained 
infertility. On the whole, the 70.8% conception rate 
recorded in patients with post – HTB evidence of 
tubal patency, also help to buttress the effectiveness of 
hydrotubation in the evaluation of tubal patency.
 In this study, the overall conception rate of 
42.4% recorded in 257 patients that had therapeutic 
hydrotubation is encouraging, when we considered 
the “hopeless” nature of these cases in a resource 
constrained setting like ours. We also found this 
procedure to be more effective in patients with 
perifimbrial adhesions (incomplete tubal occlusion), 
followed by patients with unexplained infertility 
when combined with clomiphene citrate for ovulation 
induction. The hypothesis by Sulak et al (13) that 
proximal tubal blockage is caused by plugs of 
amorphous materials that occlude the tubal lumen 
without the presence of any tubal wall damage, made 
us to include bilateral cornual end tubal blockage 
as one of the indiccution for hydrotubation. The 
pregnancy outcome is also encouraging, with term 
pregnancies mainly recorded. Outcome of pregnancies 
are comparable to figures reported with the use of 
oil-soluble media (14). Though use of oil-soluble 
contrast is associated with an increase in the odds if 
live births but not pregnancy rates when compared 
with water soluble media (14).
 The reliability on HSG for assessing the 
fallopian tubes was a major limitation of this study. 
Nonetheless, we found therapeutic HTB beneficial 
in the management of female infertility, especially 
incomplete tubal occlusion and unexplained 
infertility in resource poor settings, where modern 
technology for management are mostly unavailable 
and expensive. However, a randomised controlled 
trial with pre – HTB laparoscopic evaluation of the 
fallopian tubes is recommended, more especially 
for cases with incomplete tubal occlusion and 
unexplained infertility.
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